1-7 of 7
Cesar Rodriguez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients

Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Samir Parekh, Sundar Jagannath
Journal: Blood Advances
Blood Adv bloodadvances.2024014097.
https://doi.org/10.1182/bloodadvances.2024014097
Published: 2024
Journal Articles

Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival

Zachary M Avigan, Saoirse Bodnar, Darren Pan, Jerrel Lewis Catlett, II, Joshua Richter, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Santiago Thibaud
Journal: Blood Advances
Blood Adv bloodadvances.2024014255.
https://doi.org/10.1182/bloodadvances.2024014255
Published: 2024
Includes: Supplemental data
Journal Articles

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse

Clinical Trials & Observations
Peter Voorhees, Vera Suman, Yvonne Efebera, Noopur Raje, Sascha Tuchman, Cesar Rodriguez, Jacob Laubach, Misty Bova-Solem, Destin Carlisle, Saad Usmani, Philip McCarthy, Paul G. Richardson
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5039–5050.
https://doi.org/10.1182/bloodadvances.2024013623
Published: 2024
Includes: Supplemental data
Journal Articles

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Clinical Trials & Observations
Urvi A. Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R. Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud, Larysa Sanchez, Cesar Rodriguez, Shambavi Richard, Joshua Richter, Adriana Rossi, Hearn Jay Cho, Alexander Lesokhin, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Samir Parekh, Emily J. Gallagher
Journal: Blood Advances
Blood Adv (2024) 8 (1): 236–247.
https://doi.org/10.1182/bloodadvances.2023010815
Published: 2024
Includes: Supplemental data
Journal Articles

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P. M. Verkleij, Maria Victoria Mateos, Thomas G. Martin, Cesar Rodriguez, Ajay Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales-Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T. Kuipers, Kaz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Margaret Doyle, Hans L. Zaaijer, Sonja Zweegman, Raluca I. Verona, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2023) 8 (1): 194–206.
https://doi.org/10.1182/bloodadvances.2023011658
Published: 2023
Includes: Supplemental data
Journal Articles

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1056–1064.
https://doi.org/10.1182/bloodadvances.2022007923
Published: 2023
Includes: Supplemental data
Journal Articles

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN

Clinical Trials & Observations
Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa, Yana Lutska, Padma Bobba, Daniela Hoehn, Huiling Pei, Jon Ukropec, Ming Qi, Thomas S. Lin, Paul G. Richardson
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1092–1096.
https://doi.org/10.1182/bloodadvances.2020003642
Published: 2021